Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 32Ovarian Neoplasms 18Neoplasms 14Fallopian Tube Neoplasms 12Carcinoma, Hepatocellular 11Carcinoma, Non-Small-Cell Lung 9Endometrial Neoplasms 6Colonic Neoplasms 6Neoplasm Metastasis 5Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Lung Neoplasms 3Liver Neoplasms 3Brain Neoplasms 3Biliary Tract Neoplasms 3Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Neuroma, Acoustic 2Neurofibromatosis 2 2Mouth Neoplasms 2Meningioma 2Lymphoid Interstitial Pneumonia 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2

Interventions

pembrolizumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor, Adult × Bevacizumab × 30 days × Clear all
NCT06265688 2026-05-19

First In Human Study of CX-2051 in Advanced Solid Tumors

CytomX Therapeutics

Phase 1 Recruiting
160 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡